Correction and Requblication of : Comparative Study of Fexofenadine Up-dosing and Olopatadine Conventional Dosing in Chronic Urticaria Refractory to Fexofenadine Conventional Dosing
-
- MORITA Eishin
- Department of Dermatology, Shimane University Faculty of Medicine
-
- TAKAHASHI Hitoshi
- Department of Dermatology, Shimane University Faculty of Medicine
-
- KANEKO Sakae
- Department of Dermatology, Shimane University Faculty of Medicine
-
- CHINUKI Yuko
- Department of Dermatology, Shimane University Faculty of Medicine
-
- TOHGI Kimiko
- Togi Dermatological Clinic
-
- TAKAGAKI Kenji
- Department of Dermatology, Shimane Prefectural Central Hospital
-
- TSUJINO Yoshio
- Department of Dermatology, Shimane Prefectural Central Hospital
-
- MIHARA Yuko
- Department of Dermatology, Shimane Prefectural Central Hospital
-
- ISHITOBI Tomoko
- Department of Dermatology, Shimane Prefectural Central Hospital
-
- FUKUSHIRO Shinji
- Fukushiro Dermatological Clinic
-
- YAMADA Yoshitaka
- Yamada Dermatological Clinic
Bibliographic Information
- Other Title
-
- (修正版) フェキソフェナジン塩酸塩効果不十分な慢性蕁麻疹における増量投与と オロパタジン塩酸塩への変更投与の比較検討
- 治療 フェキソフェナジン塩酸塩効果不十分な慢性蕁麻疹における増量投与とオロパタジン塩酸塩への変更投与の比較検討
- チリョウ フェキソフェナジン エンサンエン コウカ フジュウブン ナ マンセイ ジンマシン ニ オケル ゾウリョウ トウヨ ト オロパタジン エンサンエン エ ノ ヘンコウ トウヨ ノ ヒカク ケントウ
- フェキソフェナジン塩酸塩効果不十分な慢性蕁麻疹における増量投与とオロパタジン塩酸塩への変更投与の比較検討(修正版)
- フェキソフェナジン エンサンエン コウカ フジュウブン ナ マンセイ ジンマシン ニ オケル ゾウリョウ トウヨ ト オロパタジン エンサンエン エ ノ ヘンコウ トウヨ ノ ヒカク ケントウ(シュウセイバン)
- Comparative Study of Fexofenadine Up-dosing and Olopatadine Conventional Dosing in Chronic Urticaria Refractory to Fexofenadine Conventional Dosing
- Q&A -about Vol. 76-4
Search this article
Abstract
The efficacies of fexofenadine up-dosing and olopatadine conventional dosing were comparatively evaluated by using urticaria severity score and modified urticaria activity score (mUAS) in 24 patients who had chronic urticaria refractory to fexofenadine conventional dosing (120 mg/day for 1 week). The 24 patients were randomly divided into two groups, one was treated with fexofenadine up-dosing (12 patients) and another group was treated with olopatadine conventional dosing (12 patients). The urticaria severity score was significantly decreased at the 4-week endpoint in both groups. The mUAS was significantly decreased in the fexofenadine up-dosing group at the 4-week endpoint, but in the olopatadine group the mUAS was decreased already after 2 weeks. These results indicate that both fexofenadine up-dosing and olopatadine conventional dosing are useful in chronic urticaria refractory to fexofenadine conventional dosing when taking into consideration their medical expenses.
Journal
-
- Nishi Nihon Hifuka
-
Nishi Nihon Hifuka 76 (6), 607-615, 2014
Western Division of Japanese Dermatological Association
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204301021952
-
- NII Article ID
- 130004695275
- 130005065024
- 130005065022
-
- NII Book ID
- AN00183881
-
- ISSN
- 18804047
- 03869784
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed
